Novo wins FDA approval for high-dose Wegovy under commissioner’s vouchernews2026-03-19T18:06:03+00:00March 19th, 2026|Endpoints News|
Verily raises $300M, sheds Alphabet’s majority controlnews2026-03-19T18:00:37+00:00March 19th, 2026|Endpoints News|
TerraPower’s $450M radioisotope factory; Lilly’s $126M Japan budgetnews2026-03-19T17:26:49+00:00March 19th, 2026|Endpoints News|
CSL says its hemophilia B gene therapy is out of stocknews2026-03-19T16:33:06+00:00March 19th, 2026|Endpoints News|
AstraZeneca deepens UK-China ties with cell therapy R&D hub, manufacturing plansnews2026-03-19T15:29:18+00:00March 19th, 2026|Endpoints News|
Collegium is acquiring Corium’s approved ADHD drug for $650Mnews2026-03-19T14:55:37+00:00March 19th, 2026|Endpoints News|
Pfizer seeks earlier use of Talzenna in prostate cancer with Phase 3 winnews2026-03-19T14:24:11+00:00March 19th, 2026|Endpoints News|
Washington’s Medicaid program will pay for ElliQ, an AI robot for lonelinessnews2026-03-19T13:00:43+00:00March 19th, 2026|Endpoints News|
